PTC

PTC Inc. · Technology · Software - Application
$157.15
-1.80 (-1.13%)
Mkt Cap: 18.15B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield3.5%
Dividend YieldN/A
Market Cap18.15B
Volume1.07M
Recent News
PTC Inc. (PTC) Up 16.6% Since Last Earnings Report: Can It Continue?
zacks.com · 2026-08-28
PTC Therapeutics to Participate in Upcoming Investor Conferences
prnewswire.com · 2026-08-27
PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile
prnewswire.com · 2026-08-24
PTC Therapeutics: An Acquisition Which Could Unlock Massive Potential
seekingalpha.com · 2026-08-24
PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal
marketbeat.com · 2026-08-16
PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity'
benzinga.com · 2026-08-13

Unlock the Full Deep Scan

9 AI agents analyze PTC across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →